NDASUBCUTANEOUSPOWDER
Approved
Aug 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
5/8 — Partial
CETROTIDE (cetrorelix acetate) by Gland Pharma is clinical pharmacology gnrh induces the production and release of luteinizing hormone (lh) and follicle stimulating hormone (fsh) from the gonadotrophic cells of the anterior pituitary. Approved for infertility. First approved in 2000.
Drug data last refreshed 20h ago
Mechanism of Action
CLINICAL PHARMACOLOGY GnRH induces the production and release of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the gonadotrophic cells of the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH liberation is enhanced resulting in an LH-surge. This…
Worked on CETROTIDE at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.